PACIFICO, TERESA
PACIFICO, TERESA
Università degli Studi di Roma Tor Vergata
Anthelmintic Drugs as Emerging Immune Modulators in Cancer
2023-01-01 Stolfi, C; Pacifico, T; Luiz-Ferreira, A; Monteleone, G; Laudisi, F
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut
2024-07-02 Franzè, E; Laudisi, F; Maresca, C; Di Grazia, A; Iannucci, A; Pacifico, T; Ortenzi, A; Sica, G; Lolli, E; Stolfi, C; Monteleone, I; Monteleone, G
From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling
2026-01-01 Tomassini, L; Pacifico, T; Monteleone, G; Stolfi, C; Laudisi, F
Gut Microbiota in Lipodystrophies and Obesity: A Common Signature?
2026-01-07 Colangeli, L; Teofani, A; Desideri, A; Biocca, S; Pacifico, T; Parrotta, Me; Fertitta, V; Fortini, P; Ceccarini, G; Magno, S; Pelosini, C; Santini, F; Novelli, G; Sbraccia, P; Guglielmi, V
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier
2023-01-01 Stolfi, C; Pacifico, T; Monteleone, G; Laudisi, F
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation
2026-01-01 Laudisi, F; Serra, Ma; Tomassini, L; Fantini, Mc; Monasterio, G; He, N; Sommella, Em; Ortenzi, A; Sica, Gs; Zorzi, F; Pacifico, T; Melaiu, O; De Stefanis, C; D'Oria, V; Stolfi, C; Monteleone, I; Villablanca, Ej; Monteleone, G
Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells
2026-01-01 Tomassini, L; Pacifico, T; Serra, Ma; Sommella, Em; Sambucci, M; Sica, Gs; Savino, L; Vitale, S; Ortenzi, A; Biancone, L; Battistini, L; Borsellino, G; Monteleone, I; Barnaba, V; Fiori, Me; Monteleone, G; Stolfi, C; Laudisi, F
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis
2024-11-01 Pacifico, T; Stolfi, C; Tomassini, L; Luiz-Ferreira, A; Franzè, E; Ortenzi, A; Colantoni, A; Sica, G; Sambucci, M; Monteleone, I; Monteleone, G; Laudisi, F
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis
2022-11-01 Laudisi, F; Pacifico, T; Maresca, C; Luiz-Ferreira, A; Antonelli, S; Ortenzi, A; Colantoni, A; Di Grazia, A; Franzè, E; Colella, M; Di Fusco, D; Sica, Gs; Monteleone, I; Monteleone, G; Stolfi, C
Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter
2025-07-09 Pacifico, T; Tomassini, L; Biancone, L; Monteleone, G; Stolfi, C; Laudisi, F
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance
2023-01-01 Monteleone, G; Franzè, E; Maresca, C; Colella, M; Pacifico, T; Stolfi, C
Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning
2025-01-01 Tomassini, L; Pacifico, T; Monteleone, G; Stolfi, C; Laudisi, F
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response
2024-09-27 Di Grazia, A; Franzè, E; Frascatani, R; Laudisi, F; Pacifico, T; Tomassini, L; Di Fusco, D; Formica, V; Sica, G; Stolfi, C; Monteleone, I; Monteleone, G
Targeting IL-34/MCSF-1R Axis in Colon Cancer
2022-06-28 Monteleone, G; Maresca, C; Colella, M; Pacifico, T; Congiu, D; Troncone, E; Marafini, I
TRAIL-Sensitizing Effects of Flavonoids in Cancer
2023-01-01 Luiz-Ferreira, A; Pacifico, T; Cardoso Cruz, A; Laudisi, F; Monteleone, G; Stolfi, C
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | Anthelmintic Drugs as Emerging Immune Modulators in Cancer | Stolfi, C; Pacifico, T; Luiz-Ferreira, A; Monteleone, G; Laudisi, F | Articolo su rivista | |
| 2-lug-2024 | Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut | Franzè, E; Laudisi, F; Maresca, C; Di Grazia, A; Iannucci, A; Pacifico, T; Ortenzi, A; Sica, G; Lolli, E; Stolfi, C; Monteleone, I; Monteleone, G | Articolo su rivista | |
| 1-gen-2026 | From Gut Homeostasis to Colorectal Cancer: Spatial and Temporal Reprogramming of Microbial Inosine Signaling | Tomassini, L; Pacifico, T; Monteleone, G; Stolfi, C; Laudisi, F | Articolo su rivista | |
| 7-gen-2026 | Gut Microbiota in Lipodystrophies and Obesity: A Common Signature? | Colangeli, L; Teofani, A; Desideri, A; Biocca, S; Pacifico, T; Parrotta, Me; Fertitta, V; Fortini, P; Ceccarini, G; Magno, S; Pelosini, C; Santini, F; Novelli, G; Sbraccia, P; Guglielmi, V | Articolo su rivista | |
| 1-gen-2023 | Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier | Stolfi, C; Pacifico, T; Monteleone, G; Laudisi, F | Articolo su rivista | |
| 1-gen-2026 | Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation | Laudisi, F; Serra, Ma; Tomassini, L; Fantini, Mc; Monasterio, G; He, N; Sommella, Em; Ortenzi, A; Sica, Gs; Zorzi, F; Pacifico, T; Melaiu, O; De Stefanis, C; D'Oria, V; Stolfi, C; Monteleone, I; Villablanca, Ej; Monteleone, G | Articolo su rivista | |
| 1-gen-2026 | Rafoxanide disrupts mitochondrial homeostasis through VDAC1 modulation in colorectal cancer cells | Tomassini, L; Pacifico, T; Serra, Ma; Sommella, Em; Sambucci, M; Sica, Gs; Savino, L; Vitale, S; Ortenzi, A; Biancone, L; Battistini, L; Borsellino, G; Monteleone, I; Barnaba, V; Fiori, Me; Monteleone, G; Stolfi, C; Laudisi, F | Articolo su rivista | |
| 1-nov-2024 | Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis | Pacifico, T; Stolfi, C; Tomassini, L; Luiz-Ferreira, A; Franzè, E; Ortenzi, A; Colantoni, A; Sica, G; Sambucci, M; Monteleone, I; Monteleone, G; Laudisi, F | Articolo su rivista | |
| 1-nov-2022 | Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis | Laudisi, F; Pacifico, T; Maresca, C; Luiz-Ferreira, A; Antonelli, S; Ortenzi, A; Colantoni, A; Di Grazia, A; Franzè, E; Colella, M; Di Fusco, D; Sica, Gs; Monteleone, I; Monteleone, G; Stolfi, C | Articolo su rivista | |
| 9-lug-2025 | Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter | Pacifico, T; Tomassini, L; Biancone, L; Monteleone, G; Stolfi, C; Laudisi, F | Articolo su rivista | |
| 1-gen-2023 | Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance | Monteleone, G; Franzè, E; Maresca, C; Colella, M; Pacifico, T; Stolfi, C | Articolo su rivista | |
| 1-gen-2025 | Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning | Tomassini, L; Pacifico, T; Monteleone, G; Stolfi, C; Laudisi, F | Articolo su rivista | |
| 27-set-2024 | Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response | Di Grazia, A; Franzè, E; Frascatani, R; Laudisi, F; Pacifico, T; Tomassini, L; Di Fusco, D; Formica, V; Sica, G; Stolfi, C; Monteleone, I; Monteleone, G | Articolo su rivista | |
| 28-giu-2022 | Targeting IL-34/MCSF-1R Axis in Colon Cancer | Monteleone, G; Maresca, C; Colella, M; Pacifico, T; Congiu, D; Troncone, E; Marafini, I | Articolo su rivista | |
| 1-gen-2023 | TRAIL-Sensitizing Effects of Flavonoids in Cancer | Luiz-Ferreira, A; Pacifico, T; Cardoso Cruz, A; Laudisi, F; Monteleone, G; Stolfi, C | Articolo su rivista |